Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | CSNK1A1 | P48729 | 2/20 | 0.36 |
| ▸ | CSNK1D | P48730 | 2/20 | 0.36 |
| ▸ | GSK3B | P49841 | 2/20 | 0.36 |
| ▸ | CSNK1G2 | P78368 | 2/20 | 0.36 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.35 |
| ▸ | MCHR1 | Q99705 | 9/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29987322 | 1.00 | GRM5 (0.40) | GRM5SLC6A3CSNK1A1CSNK1DGSK3B | |
| SCHEMBL24667378 | 0.86 | GRM5 (0.40) | GRM5SLC6A3CSNK1A1CSNK1DGSK3B | |
| SCHEMBL29987385 | 0.86 | GRM5 (0.40) | GRM5SLC6A3CSNK1A1CSNK1DGSK3B | |
| SCHEMBL29987068 | 0.85 | GRM5 (0.42) | GRM5SLC6A3PDE10AMCHR1 | |
| SCHEMBL24667632 | 0.85 | GRM5 (0.42) | GRM5SLC6A3PDE10AMCHR1 | |
| SCHEMBL24667777 | 0.85 | GRM5 (0.39) | GRM5SLC6A3CSNK1A1CSNK1DGSK3B | |
| SCHEMBL29986601 | 0.85 | GRM5 (0.39) | GRM5SLC6A3CSNK1A1CSNK1DGSK3B | |
| SCHEMBL24667444 | 0.84 | GRM5 (0.36) | GRM5SLC6A3PDE10AMCHR1 | |
| SCHEMBL24667793 | 0.84 | GRM5 (0.38) | GRM5SLC6A3CSNK1A1CSNK1DGSK3B | |
| SCHEMBL29987317 | 0.84 | GRM5 (0.36) | GRM5SLC6A3PDE10AMCHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117412960-A | Isoindolinone compounds and imaging agents for imaging huntingtin | CHDI基金会股份有限公司 | 2024-01-16 | — | — | CN | disclosed |
| US-20220339302-A1 | ISOINDOLINONE COMPOUNDS AND IMAGING AGENTS FOR IMAGING HUNTINGTIN PROTEIN | CHDI FOUNDATION, INC. | 2022-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220339302-A1 | ISOINDOLINONE COMPOUNDS AND IMAGING AGENTS FOR IMAGING HUNTINGTIN PROTEIN | HTT, HYPK, HSPBP1 | GRM5 1943/4885SLC6A3 1916/4885CSNK1A1 2581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.